Abu Dhabi sovereign investment giant Mubadala has teamed with British Patient Capital to back SV Health Investors’ Biotech Crossover Opportunities Fund.
The post Mubadala, British Patient Capital back SV Health growth biotech fundraise first appeared on AltAssets Private Equity News.
